Sep 23 2026 01:12 AM EST

Rogers Sugar Shares Edge Lower as Sugar Volumes Contract Despite Margin Gains

Rogers Sugar Inc. (TSX: RSI) reported a second‑quarter revenue decline of 16.8% year‑over‑year to CAD 281 million, followed by an eighth‑percent drop in the third quarter to CAD 293.7 million. Despite the top‑line weakness, adjusted EBITDA rose 10% YoY in Q2 to CAD 38 million, and free cash flow improved to CAD 93 million, prompting investors to reassess the company’s earnings quality and dividend sustainability.

Q2‑Q3 Results: Revenue Down, Margins Up

The sugar segment’s revenue fell CAD 55.9 million YoY in Q2, reflecting lower Raw #11 prices (down 4.8 ¢/lb) and a 12% volume reduction to 174,800 t. Yet the segment delivered an adjusted gross margin of CAD 46.9 million, up CAD 8.5 million YoY, translating to a per‑tonne margin increase of $268.

The maple segment posted a modest revenue decline of CAD 1.6 million YoY in Q2, with adjusted EBITDA slipping to CAD 4.8 million. Nevertheless, the business generated CAD 6.8 million in adjusted gross margin, supporting overall profitability.

LEAP Expansion and Capital Structure

The LEAP (Eastern Expansion) project, targeting an additional 100,000 metric tonnes of refined‑sugar capacity, remains on schedule for a first‑half‑2027 start‑up. Capitalized costs stand at CAD 178.2 million, with a 2026 spend of roughly CAD 115 million. Funding combines a CAD 57.5 million equity raise (11.1 million shares at $5.18) and a convertible debenture upsized to CAD 100 million.

Non‑LEAP capex for FY2026 is projected at CAD 27 million. The company’s balance sheet remains strong, with a debt‑to‑equity ratio of 0.05 and a current ratio of 1.87, while free cash flow exceeds CAD 90 million on a trailing‑12‑month basis.

Macro Environment Pressuring Demand and Costs

Raw‑sugar price volatility, driven by Brazilian real fluctuations, El Niño forecasts, and US‑Brazil trade dynamics, has reduced input cost pass‑through. The CAD/USD exchange rate continues to affect imported raw‑cane costs, while higher energy and transportation prices—exacerbated by Middle‑East conflicts—have pressured operating expenses.

Demand‑side headwinds include food‑price inflation, which curtails consumer spending on discretionary items, and evolving health guidelines that may depress long‑term sugar consumption. Analysts also flagged potential US tariffs on refined‑sugar exports and the rising adoption of GLP‑1 weight‑loss drugs as longer‑term demand risks.

Analyst Sentiment and Valuation

Scotiabank downgraded the stock to “strong sell” on 6 Feb 2026, citing a price target of C$6.00 amid concerns over volume contraction. Conversely, TipRanks maintained a “Hold” rating on 8 May 2026 with a target of C$7.00, reflecting optimism about margin expansion and the LEAP project’s future capacity.

Trailing‑12‑month operating margin improved to 9.3% (up from 7.5% in 2024), while gross‑profit margin rose to 16.5%. The stock’s recent five‑day performance of ‑1.2% mirrors investor caution despite these profitability gains.

Risks and Outlook

Key risks include continued volume declines in the sugar segment, potential US trade barriers, and the long‑term impact of health‑policy shifts that could erode sugar demand. The LEAP project, while strategically important, adds financing costs and execution risk; any delay or cost overrun could strain cash‑flow coverage.

Management has reaffirmed FY2026 guidance for a modestly lower sugar volume of 735,000 t (‑6% YoY) and a 5% increase in maple volume to 56 million lb. Investors will watch the first‑half‑2027 LEAP start‑up, upcoming CITT regulatory reviews, and any changes to U.S. tariff policy for signals on future earnings momentum.